Covered recipient · General Payments record
WENDY WONG
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$5,064.33
- Reported across 266 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $793.14 | 31 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $177.60 | 6 |
| Novo Nordisk AS | $150.90 | 7 |
| Gilead Sciences, Inc. | $121.84 | 1 |
| PFIZER INC. | $100.09 | 5 |
| ABBVIE INC. | $87.23 | 5 |
| Exact Sciences Corporation | $62.78 | 3 |
| Acerta Pharma LLC | $48.34 | 2 |
| GlaxoSmithKline, LLC. | $27.45 | 1 |
| Amgen Inc. | $16.91 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.48 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106356515 | CMS |
| ABBVIE INC. | $20.37 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106356517 | CMS |
| ABBVIE INC. | $14.34 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106356519 | CMS |
| ABBVIE INC. | $21.64 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106356521 | CMS |
| ABBVIE INC. | $16.40 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106356523 | CMS |
| Amgen Inc. | $16.91 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117721116 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.25 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104645913 | CMS |
| AstraZeneca Pharmaceuticals LP | $26.09 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104583452 | CMS |
| Exact Sciences Corporation | $26.03 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114953346 | CMS |
| Exact Sciences Corporation | $15.73 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114953350 | CMS |
| Exact Sciences Corporation | $21.02 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114953354 | CMS |
| Gilead Sciences, Inc. | $121.84 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133740162 | CMS |
| GlaxoSmithKline, LLC. | $27.45 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116714571 | CMS |
| Lilly USA, LLC | $16.92 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135477852 | CMS |
| Lilly USA, LLC | $93.85 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135496212 | CMS |
| Lilly USA, LLC | $16.90 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135496214 | CMS |
| Lilly USA, LLC | $15.39 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135453215 | CMS |
| Lilly USA, LLC | $13.42 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135512954 | CMS |
| Lilly USA, LLC | $21.12 | 08/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135512956 | CMS |
| Novo Nordisk Inc | $23.23 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097395829 | CMS |
| Novo Nordisk Inc | $23.25 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096714919 | CMS |
| Novo Nordisk Inc | $23.67 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097178145 | CMS |
| Novo Nordisk Inc | $11.64 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097819694 | CMS |
| Novo Nordisk Inc | $23.36 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096903957 | CMS |
| Novo Nordisk Inc | $28.32 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097131126 | CMS |
| Novo Nordisk Inc | $17.43 | 12/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097446127 | CMS |
| PFIZER INC. | $18.87 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131400503 | CMS |
| PFIZER INC. | $17.36 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131352810 | CMS |
| PFIZER INC. | $15.43 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131779110 | CMS |
| PFIZER INC. | $22.53 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131651379 | CMS |
| PFIZER INC. | $25.90 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132093684 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.